DOPAFUSE Trademark

Trademark Overview

On Tuesday, May 7, 2019, a trademark application was filed for DOPAFUSE with the United States Patent and Trademark Office. The USPTO has given the DOPAFUSE trademark a serial number of 88418888. The federal status of this trademark filing is REGISTERED as of Tuesday, June 15, 2021. This trademark is owned by SynAgile Corporation. The DOPAFUSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of neurological disorders, namely, Parkinson's Disease

General Information

Serial Number88418888
Word MarkDOPAFUSE
Filing DateTuesday, May 7, 2019
Status700 - REGISTERED
Status DateTuesday, June 15, 2021
Registration Number6389896
Registration DateTuesday, June 15, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 3, 2019

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of neurological disorders, namely, Parkinson's Disease
Pseudo MarkDOPA FUSE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 22, 2019
Primary Code005
First Use Anywhere DateTuesday, March 30, 2021
First Use In Commerce DateTuesday, March 30, 2021

Trademark Owner History

Party NameSynAgile Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWilson, WY 83014
US
Party NameSynAgile Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilson, WY 83014
US
Party NameSynAgile Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilson, WY 83014
US

Trademark Events

Event DateEvent Description
Friday, May 10, 2019NEW APPLICATION ENTERED
Wednesday, May 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 22, 2019ASSIGNED TO EXAMINER
Monday, July 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 14, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 3, 2019PUBLISHED FOR OPPOSITION
Tuesday, September 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 21, 2020SOU EXTENSION 1 FILED
Tuesday, April 21, 2020SOU EXTENSION 1 GRANTED
Thursday, April 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 21, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, October 21, 2020SOU EXTENSION 2 FILED
Wednesday, October 21, 2020SOU EXTENSION 2 GRANTED
Friday, October 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 7, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, April 7, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, April 21, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 7, 2021SOU EXTENSION 3 FILED
Thursday, April 22, 2021SOU EXTENSION 3 GRANTED
Wednesday, April 7, 2021USE AMENDMENT FILED
Thursday, April 22, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, April 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 12, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 13, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 15, 2021REGISTERED-PRINCIPAL REGISTER
Monday, June 15, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

dopafuse parkinson disease namely disorders treatment neurological pharmaceuticals